Health & Medicine Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health & Medicine Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Antifungals
Immunocompromised pediatric patients can be treated safely with caspofungin
October 27th, 2003
Immunocompromised pediatric patients can be treated with caspofungin. According to recent research from the United States, "Caspofungin is an antifungal medication proved efficacious and well tolerated in adults. "Twenty-five pediatric patients at St. Jude Children's Research Hospital who had received at least 1 dose of caspofungin were identified, and their records were reviewed retrospectively. Caspofungin was well tolerated; only 3 patients experienced any adverse event judged possibly related to drug," wrote J.A. Franklin and colleagues. The researchers concluded: "Caspofungin appears to be safe in immunocompromised pediatric...
Source: Health & Medicine Week (2003-10-27)
|
